⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CVAC News
CureVac N.V. Ordinary Shares
Global mRNA Cancer Vaccines Market Report 2026-2031: Assesses More Than 70 Vaccines Through Phase III
globenewswire.com
BNTX
MRNA
CVAC
TRNS
Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight
globenewswire.com
NVO
LLY
BMY
AXSM
JNJ
SNY
BIIB
ABBV
MRK
REGN
GILD
AMGN
AZN
TEVA
BHC
ALKS
VRTX
SRPT
CRIS
NTLA
EDIT
INCY
ACAD
ALNY
CYTK
IONS
EXAS
IDXX
VNDA
SUPN
RGNX
XOM
CVAC
BNTX
ARCT
MRNA
NBIX
ADPT
AVXL
IMUX
PRGS
RDNT
CRDF
ADSK
ANAB
ATRC
CLDX
CPRX
ESPR
EXEL
FGEN
GALT
GRFS
HRMY
IGC
INSM
KODK
LAKE
LCTX
LEXX
LPCN
MESO
MITK
MNKD
MSFT
MYGN
NEO
NVCR
NXPI
OCGN
OMER
ORCL
PACB
PFE
PLRX
PRGO
PSNL
PTGX
QGEN
RARE
ROST
RVMD
SEIC
SIGA
SMCI
SNOW
SOFI
SPRO
TGTX
TNDM
TXG
ULTA
VEEV
VKTX
VRNS
WVE
XRAY
ZBRA
ZNTL
Messenger RNA (mRNA) Market Projected to Reach $20.99 Billion by 2035 - Moderna, Pfizer, and Others Propel mRNA Expansion into New Therapeutic Areas
globenewswire.com
ARCT
MRNA
PFE
SNY
AZN
CVAC
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
globenewswire.com
CVAC
BNTX
SNY
AMGN
NVS
PFE
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
accessnewswire.com
EVO
QGEN
CVAC
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
globenewswire.com
BNTX
CVAC
BMY
BioNTech Achieves Minimum Condition in CureVac Exchange Offer
globenewswire.com
BNTX
CVAC
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
globenewswire.com
BNTX
CVAC
CureVac Announces Voting Results of Extraordinary General Meeting
accessnewswire.com
CVAC
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates
accessnewswire.com
CVAC